0001209191-19-048804.txt : 20190906 0001209191-19-048804.hdr.sgml : 20190906 20190906174638 ACCESSION NUMBER: 0001209191-19-048804 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190905 FILED AS OF DATE: 20190906 DATE AS OF CHANGE: 20190906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cory David A CENTRAL INDEX KEY: 0001670137 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 191080482 MAIL ADDRESS: STREET 1: 350 CAMBRIDGE AVENUE, SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-05 0 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001670137 Cory David A C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 1 1 0 0 President and CEO Common Stock 2019-09-05 5 A 0 E 1500 7.9475 A 67846 D Common Stock 29780 I See footnote These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person is a managing member and significant equity interest holder of Eiccose. The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein. /s/ Sriram Ryali, Attorney-in-Fact 2019-09-06